ストックスクリーナーアプリを入手
2.46
1.62%
-0.01
前日終値:
$2.47
開ける：
$2.42
24時間の取引高:
29,544
Relative Volume:
0.09
時価総額：
$5.94M
収益：
-
当期純損益:
$-7.32M
株価収益率:
-5.6203
EPS:
-0.4377
ネットキャッシュフロー:
$-5.99M
1週間 パフォーマンス:
+1.67%
1か月 パフォーマンス:
+0.00%
6か月 パフォーマンス:
-68.56%
1年 パフォーマンス:
-70.45%
1日の値動き範囲:
$2.3801
$2.4699
1週間の範囲:
$2.27
$2.47
52週間の値動き範囲:
$2.10
$16.80
Mangoceuticals Inc Stock (MGRX) Company Profile
名前
Mangoceuticals Inc
セクター
電話
(833) 626-4679
住所
15110 DALLAS PKWY, SUITE 600, DALLAS
MGRX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
| MGRX | 2.46 | 5.94M | 0 | -7.32M | -5.99M | -0.4377 |
| VEEV | 213.88 | 33.92B | 2.57B | 615.26M | 996.76M | 3.32 |
| SOLV | 69.30 | 11.55B | 8.25B | 404.00M | 1.52B | 0.00 |
| DOCS | 49.77 | 9.32B | 493.63M | 160.55M | 162.20M | 0.55 |
| TEM | 55.08 | 9.04B | 640.44M | -743.28M | -206.93M | 0.00 |
| HQY | 103.29 | 8.87B | 1.10B | 105.67M | -197.98M | 0.1475 |
Mangoceuticals Inc (MGRX) 最新ニュース
Mangoceuticals Inc. (MGRX) Quarterly 10-Q Report - Quartzy
Mangoceuticals Signs Consulting Deal with CFO Johnston - TipRanks
Mangoceuticals (MGRX) versus Its Competitors Head-To-Head Contrast - Defense World
Financial Comparison: Mangoceuticals (MGRX) versus Its Competitors - Defense World
Mangoceuticals (MGRX) and The Competition Head-To-Head Comparison - Defense World
Head to Head Survey: Mangoceuticals (MGRX) vs. The Competition - Defense World
Head to Head Review: Mangoceuticals (MGRX) versus Its Competitors - Defense World
Head-To-Head Analysis: Mangoceuticals (MGRX) vs. The Competition - Defense World
Mangoceuticals (MGRX) & Its Competitors Head to Head Comparison - Defense World
Reviewing Mangoceuticals (MGRX) & Its Competitors - Defense World
Financial Survey: Mangoceuticals (MGRX) & Its Competitors - Defense World
Mangoceuticals (MGRX) versus Its Peers Head to Head Comparison - Defense World
Mangoceuticals (MGRX) & Its Competitors Financial Analysis - Defense World
Head-To-Head Contrast: Mangoceuticals (MGRX) & The Competition - Defense World
Mangoceuticals (MGRX) versus The Competition Head to Head Survey - Defense World
Reviewing Mangoceuticals (MGRX) & Its Rivals - Defense World
Mangoceuticals (NASDAQ:MGRX) Regains Compliance with Nasdaq Minimum Bid Price Requirement - Defense World
Head to Head Analysis: Mangoceuticals (NASDAQ:MGRX) & NewGenIvf Group (NASDAQ:NIVF) - Defense World
Head to Head Review: Mangoceuticals (MGRX) & Its Rivals - Defense World
Financial Analysis: Mangoceuticals (MGRX) vs. Its Peers - Defense World
Mangoceuticals, Inc. Regains Full Compliance with Nasdaq Minimum Bid Price Requirement - GlobeNewswire
Mangoceuticals regains full compliance with Nasdaq min bid price requirement - TipRanks
Analyzing Mangoceuticals (MGRX) and Its Competitors - Defense World
Mangoceuticals (MGRX) and Its Peers Financial Comparison - Defense World
Head-To-Head Contrast: Mangoceuticals (MGRX) & Its Peers - Defense World
Head to Head Analysis: Mangoceuticals (MGRX) vs. Its Competitors - Defense World
Financial Review: Mangoceuticals (MGRX) & Its Peers - Defense World
Comparing Mangoceuticals (MGRX) and Its Peers - Defense World
Mangoceuticals issues shares, raises $78,787 in capital By Investing.com - Investing.com South Africa
Head to Head Analysis: Mangoceuticals (NASDAQ:MGRX) vs. NewGenIvf Group (NASDAQ:NIVF) - Defense World
Mangoceuticals issues shares, raises $78,787 in capital - Investing.com India
Reviewing Mangoceuticals (MGRX) & The Competition - Defense World
Mangoceuticals (MGRX) & Its Rivals Critical Comparison - Defense World
Comparing Mangoceuticals (MGRX) & Its Rivals - Defense World
Mangoceuticals Responds to Claims Made by Eli Lilly in Recent Press Release - Defense World
Head to Head Review: Mangoceuticals (MGRX) versus Its Rivals - Defense World
Mangoceuticals explores strategic alternatives to boost shareholder value By Investing.com - Investing.com Australia
Mangoceuticals explores strategic alternatives to boost shareholder value - Investing.com
MangoRx Announces Formation of Strategy and Alternatives Committee - GlobeNewswire
Mangoceuticals refutes claims made by Lilly in weight-loss drug lawsuit - MSN
Mangoceuticals refutes claims made by Lilly in weight-loss drug lawsuit (NASDAQ:MGRX) - Seeking Alpha
Mangoceuticals Board Initiates Process to Evaluate Strategic Alternatives - Marketscreener.com
Mangoceuticals Defends Against Eli Lilly Allegations - TipRanks
MangoRx Responds to and Refutes Recent Claims Made by Eli Lilly - ForexTV.com
MangoRx faces lawsuit from Eli Lilly over medication - Investing.com
Mangoceuticals ‘refutes’ claims by Eli Lilly regarding sale of tirzepatide - TipRanks
Mangoceuticals Inc (MGRX) 財務データ
収益
当期純利益
現金流量
EPS
Mangoceuticals Inc (MGRX) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Hamilton Alex P. | Director |
Jun 25 '24 |
Sale |
0.31 |
16,574 |
5,138 |
158,426 |
0.55%
0.22%
大文字化:
|
ボリューム (24 時間):